Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,742,419
+$9,431,483 QoQ
Shares Held
137,838
+293.1% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cinctive Capital Management LP holds $203,047,008 across 45 Biotechnology names. CYTK ranks #4 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 350,165 | $46,477,400 | |||
| 2 | INSM |
INSMED Inc
|
161,996 | $17,272,013 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,712 | $13,268,651 | |
| 4 | CYTK |
Cytokinetics Inc
This page
|
137,838 | $11,742,419 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
226,140 | $8,003,094 | |
| 6 | NTHI |
Neonc Technologies Holdings, Inc.
|
1,607,464 | $7,281,811 | |
| 7 | ERAS |
Erasca, Inc.
|
391,642 | $7,174,881 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
16,367 | $6,083,122 |
All Filings in CYTK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,742,419 | 137,838 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,310,936 | 35,062 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $416,949 | 6,562 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,806,029 | 105,641 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $2,102,780 | 52,321 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $1,252,350 | 15,000 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||